Skip to main content

Correction to: Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis

The Original Article was published on 07 January 2022

Correction to: Cancer Cell International (2022) 22:13

https://doi.org/10.1186/s12935-021-02368-y

Following the publication of the original article [1], we were notified of an error in Fig. 1H. The corrected Fig. 1H can be found below.

Fig. 1
figure 1

YTHDF2 overexpression promotes cell proliferation and invasion in LUSC. A and B Representative immunoblot showed that the protein level of YTHDF2 was steadily up‑regulated in two LUSC cell lines studied. The CCK8 assay was used to assess cell viability in NCI‑H226 and SK‑MES‑1 cells. C and D The transwell assay and the wound‑healing assay were used to assess the invasion potential and migration ability of NCI‑H226 and SK‑MES‑1 cells. E and F Tumor size was measured twice a week. After 5 weeks, we dissected tumors from nude mice which had been injected with the indicated stable cell, then measured the tumor size and weight of nude mice injected with the indicated stable cells. G and H Immunohistochemistry showed the expression level of YTHDF2 from tumors of nude mice injected with the indicated stable cells. Data are represented by the mean ± SD of three independent experiments. *P < 0.05 vs. the vector group

References

  1. Xu P, Hu K, Zhang P, Sun ZG, Zhang N. Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis. Cancer Cell Int. 2022;22(1):13. Published 2022 Jan 7. doi:https://doi.org/10.1186/s12935-021-02368-y.

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhi-Gang Sun or Nan Zhang.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12935-021-02368-y.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, P., Hu, K., Zhang, P. et al. Correction to: Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis. Cancer Cell Int 23, 179 (2023). https://doi.org/10.1186/s12935-023-03030-5

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12935-023-03030-5